Rafi M. Khan, a stockbroker who has been charged with stock manipulation by the Securities and Exchange Commission (“SEC”), has been tied to Hemispherx Biopharma, Inc. (AMEX: HEB) (Price: $7.125). In a July 30, 1998 […]
A September 21, 1998 press release from Hemispherx Biopharma, Inc. (AMEX: HEB) (Price: $7.6875) regarding Ampligen quoted an unnamed spokesperson for CFIDS Network, Inc., a chronic fatigue syndrome advocacy group, as stating that “Ampligen works […]
On October 15, 1998 the FDA sent a violation notice to Dr. William Carter, CEO of Hemispherx Biopharma, Inc. (AMEX: HEB) (Price: $7.9375), that required Hemispherx to cease making claims of safety and efficacy for […]
U.S. Secretary of Commerce William M. Daley has confirmed that the Department of Commerce (“DOC”) only approved Network Solutions, Inc.’s (NASDAQ: NSOL) (Price: $78.375) license agreement with ICANN’s accredited testbed participants for use during Phase […]
ICANN has reported meeting fierce resistance and indirect opposition from Network Solutions Inc., (NASDAQ: NSOL) (Price: $78.375) which includes funding and encouraging certain individuals and entities to act to attempt to delay the process of […]
Harris Freedman and Sharon Will, who have been vice presidents of Hemispherx Biopharma Inc. (AMEX: HEB) (Price: $7.75) since 1994, and a former Hemispherx board member, Stephen J. Drescher, have been associated with three of […]
On October 12, 1998, an Asensio & Company, Inc. official notified the now-departing Chairman of the American Stock Exchange (“AMEX”), Richard F. Syron, that the firm had material information concerning the Hemispherx Biopharma, Inc. (AMEX: […]
The following is a not-all-inclusive list in outline form of certain material fraudulent and false statements that are included in Hemispherx Biopharma, Inc.’s (AMEX symbol: HEB) (Price: $7.625) public filings and promotional investor solicitation documents. […]
A Hemispherx Biopharma, Inc. (AMEX: HEB) (Price: $7.9375) report recently issued by Value Management & Research AG (“VMR”), a Germany-based asset-management firm, claims that AIDS researchers are now returning to “immune modulators” because currently used […]
Three months ago, on February 8, 1999, Network Solutions, Inc.’s (NASDAQ Symbol: NSOL) (Price: $68.1875) controlling, majority shareholder sold the pre-split equivalent of 9 million shares of their NSOL common stock to the investing public […]
VIA FACSIMILE (202) 482-2741 April 28, 1999 William M. Daley Secretary United States Department of Commerce 14th and Constitution Avenues Washington D.C. 20230 Dear Secretary Daley: Asensio & Company, Inc. (“Asensio”) is a New York […]
The U.S. Department of Commerce (“DOC”) has limited the registry fee Network Solutions, Inc. (NASDAQ Symbol: NSOL) (Price: $92.00) can temporarily charge the ICANN accredited test bed participants to no more than $9 per domain […]
False Publicity Bars Turbodyne From Trade – Los Angeles Times
[Asensio] concluded with a prediction that Turbodyne stock would fall below $1 a share. [It fell to a $0.01 low.] Benjamin Mark Cole, Los Angeles Times
Playing a pivotal role in the downfall of Turbodyne was the well-known New York short trader Manuel Asensio, who released a bluntly worded report… Benjamin Mark Cole, Los Angeles Times
Last Friday, April 9th, after the close of trading, Network Solutions, Inc. (NASDAQ Symbol: NSOL) (Price: $108.00) re-established an InterNIC web site, which it had eliminated two weeks ago. U.S. taxpayers paid for the development […]
A Prudential Securities Incorporated report dated April 7, 1999 states that Amendment 11 stipulates that both ICANN and each of the registrars must have separate agreements with Network Solutions, Inc.’s (NASDAQ Symbol: NSOL) (Price: $115.50) […]
Network Solutions, Inc. (NASDAQ: NSOL) (Price: $115.50) is attempting to obtain authorization from the U.S. Department of Commerce (“DOC”) to charge ICANN’s accredited registrars a $16 fee for each one-year domain name registration for operating […]
$8 million Diana settlement proposed – Milwaukee Journal Sentinel
Failing grade for E-ZPass in N.J. – New York Post
Samples… – Money.com
Selling Short on NSI – ABCNews.com
On February 26, 1999 the U.S. Department of Commerce’s (“DOC”) National Telecommunications and Information Administration Agency (“NTIA”) formally advised Network Solutions, Inc. (NASDAQ: NSOL) (Price: $110.00) that the Internet Corporation for Assigned Names and Numbers […]
Investors may be buying Network Solutions, Inc.’s (NADAQ Symbol: NSOL) (Price: $110.00) stock believing the company possesses some market advantage, recurring income or proprietary technology that has allowed it to create, and will allow it […]
On March 12, 1999, the United States District Court for the Eastern District of Pennsylvania issued a Memorandum Decision in the litigation between Hemispherx Biopharma, Inc. (Amex: HEB) (Price: $6.375),and Asensio & Company, Inc. (“Asensio”). […]
Able Telcom Holding Corp. (NASDAQ Symbol: ABTE) (Price: $8.75) fraudulently inflated its reported first quarter earnings by at least $7 million through the reversal of a false reserve it booked in the prior quarter. Able […]
Able Telcom Holding Corp. (NASDAQ: ABTEE) (Price: $6.9375) expects to recognize a $3.3 million loss on the purchase of its notes and $10 million on the purchase of its Series B preferred stock. These $13.3 […]
Under an agreement dated April 7, 1998, Able Telcom Holding Corp. (Symbol: ABTEE) (Price: $6.8125) engaged Kaufman Bros., L.P. as Able’s financial advisor. Under this agreement, Able agreed to pay Kaufman Bros. a retainer of […]
Able Telcom Holding Corp.’s (Symbol: ABTEE) (Price: $6.8125) Form 10K included a financial statement showing net income of $2.5 million, operating cash flow of $6.9 million and shareholders’ equity of $40.2 million. These figures were […]
Able Telcom, Smarting from Deal To Buy MFS, Draws Short Sellers – The Wall Street Journal
© Asensio.com. All rights reserved.